E11.32
Type 2 diabetes mellitus with mild nonproliferative diabetic retinopathy
Clinical Classification Guidelines
Inclusion Terms
- Type 2 diabetes mellitus with nonproliferative diabetic retinopathy NOS
7th Character Definition
One of the following 7th characters is to be assigned to codes in subcategory E11.32 to designate laterality of the disease:
Medical Intelligence & Overview
Type 2 diabetes mellitus with mild nonproliferative diabetic retinopathy is a condition where high blood sugar levels associated with type 2 diabetes begin to affect the small blood vessels in the retina, leading to early signs of eye damage. This condition is classified under ICD-10 code E11.32 and signifies the presence of mild nonproliferative diabetic retinopathy, a common complication of diabetes that can impact vision if left unmanaged. Diabetic retinopathy occurs when elevated blood glucose damages the tiny vessels in the retina, the light-sensitive tissue at the back of the eye. Early detection and management are crucial to prevent progression to more severe stages that threaten sight.
Causes & Symptoms
Clinical Causes: Chronic high blood sugar levels associated with poorly controlled type 2 diabetes Hypertension or high blood pressure that worsening blood vessel damage Elevated blood cholesterol levels contributing to vessel damage Duration of diabetes: the longer a person has diabetes, the higher the risk of developing retinopathy Smoking, which can impair blood circulation and worsen tissue damage
Key Symptoms: Minimal or no noticeable symptoms in early stages Blurred vision occasionally Dark spots or floaters in the vision Difficulty perceiving colors or subtle changes in vision Vision loss that may occur as the condition progresses if untreated
Diagnostic & Treatment
Diagnosis Path: Diagnosis of this condition involves a comprehensive eye examination by an eye care professional, including dilated fundus examination, which allows detailed visualization of the retina. Additional tests such as optical coherence tomography (OCT) and fluorescein angiography may be used to assess the extent of blood vessel damage and retinal changes. Early detection is key to managing and monitoring the progression of diabetic retinopathy.
Treatment Protocols: Management strategies aim to control blood sugar levels, blood pressure, and cholesterol to slow disease progression. Specific treatments for diabetic retinopathy at this stage include: - Regular eye examinations for ongoing monitoring - Tight blood glucose control to prevent worsening of retinopathy - Laser treatment, such as focal or scatter laser therapy, used if retinopathy progresses - Managing systemic conditions like hypertension and cholesterol - Educating patients about the importance of maintaining a healthy lifestyle, including diet and exercise When retinopathy advances to proliferative stages, more invasive treatments like vitrectomy may be necessary. Early intervention and diligent management can significantly reduce the risk of vision loss.
Clinical Advice & FAQs
Billing Guidance
Is E11.32 a billable ICD-10 code?
Yes, E11.32 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report E11.32?
Clinical documentation must specify the nature of Type 2 diabetes mellitus with mild nonproliferative diabetic retinopathy and any associated comorbidities for accurate reporting.
Cite this Clinical Reference